StonvexLoading…
StonvexStonvexStonvexCore line items from CON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $569.55M | $2.16B | $1.62B | $1.05B |
Operating Income | $95.61M | $333.99M | $264.33M | $169.86M |
Net Income | $50.49M | $166.41M | $131.73M | $44.56M |
EPS (Diluted) | $0.39 | $1.30 | $1.03 | $0.65 |
Total Assets | $2.89B | $2.86B | $2.84B | $2.84B |
Total Liabilities | $2.44B | $2.44B | $2.43B | $2.47B |
Cash & Equivalents | $61.70M | $79.90M | $49.94M | $73.87M |
Free Cash Flow OCF − CapEx | $9.93M | $197.06M | $98.54M | $59.12M |
Shares Outstanding | 127.96M | 128.63M | 128.17M | 128.17M |